Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,403,867 papers from all fields of science
Search
Sign In
Create Free Account
dihydronitidine
Known as:
nitidine, dihydro-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Benzophenanthridines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Rapid structural characterization of isomeric benzo[c]phenanthridine alkaloids from the roots of Zanthoxylum nitidium by liquid chromatography combined with electrospray ionization tandem mass…
Min Cai
,
Yan Zhou
,
Xiaoling Wang
,
Rui-Qing Li
,
X. Liao
,
L. Ding
Rapid Communications in Mass Spectrometry
2007
Corpus ID: 38081978
The fragmentation mechanism of six alkaloids, namely: dihydronitidine, dihydrochelerythrine, 8-acetonyldihydronitidine, 8…
Expand
1992
1992
The formation and crystal structure of dihydronitidine and discussion of anticancer mechanism of nitidine cation.
Y. Z. Chen
,
G. Tang
,
+4 authors
Z. Huang
Science in China. Series B, Chemistry, life…
1992
Corpus ID: 37811008
The paper reports the formation and crystal structure of dihydronitidine, expounds the reasons and conditions of easily formed…
Expand
1992
1992
The formation and crystal structure of dihydronitidine and discussion of anticancer mechanism of nitidine cation.
Chen Yz
,
Tang Gy
,
+4 authors
Huang Zx
1992
Corpus ID: 99108267
The paper reports the formation and crystal structure of dihydronitidine, expounds the reasons and conditions of easily formed…
Expand
1984
1984
A Contribution to the Phytochemistry of Zanthoxylum tessmannii 1
J. F. Ayofor
,
B. T. Ngadjui
,
B. Sondengam
,
E. Tsamo
Planta Medica
1984
Corpus ID: 12789625
Zanthoxylum tessmannii Comb. nov. Fagara tessmannii Zanthoxylum tessmannii
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE